Last updated: July 4, 2026

For years, women dealing with urinary incontinence faced a limited choice: conservative management with pelvic floor exercises or invasive surgical repair. That binary is shifting. A 2026 peer-reviewed comparative study published in MDPI’s Healthcare journal directly examined Emsella HIFEM therapy against traditional surgical anterior colporrhaphy, positioning the non-invasive chair treatment as a potential alternative for suitable candidates. Orange County Plastic Surgery, led by Dr. Juris Bunkis and Dr. Deborah Ekstrom, offers this emerging option to patients in Newport Beach and surrounding communities including Tustin, Fountain Valley, and Laguna Beach.

What Is Emsella and How Does the Kegel Throne Work?

Emsella is an FDA-cleared non-invasive device that uses high-intensity focused electromagnetic (HIFEM) technology to stimulate deep pelvic floor contractions. Often referred to colloquially as the “Kegel Throne,” the treatment delivers thousands of supramaximal contractions per session while the patient remains fully clothed and seated in a specialized chair. This approach differs fundamentally from voluntary Kegel exercises, which most patients perform incorrectly or inconsistently.

How Does HIFEM Technology Address Urinary Incontinence?

Emsella HIFEM technology generates a magnetic field that penetrates tissue to directly depolarize pelvic floor motor neurons, triggering intense muscle contractions that cannot be achieved through voluntary effort alone. Each 28-minute session produces approximately 11,000 supramaximal contractions, equivalent to performing 11,000 correctly-executed Kegel exercises. These deep contractions remodel and strengthen the pelvic floor musculature, restoring urethral support and improving bladder control. Clinical studies demonstrate measurable increases in pelvic floor muscle thickness and force following treatment protocols, addressing the underlying muscular weakness that contributes to stress urinary incontinence.

What Conditions Can Emsella Treat?

Emsella is primarily indicated for stress urinary incontinence (SUI) in women, characterized by urine leakage during activities that increase abdominal pressure, such as coughing, sneezing, laughing, or exercise. The treatment also addresses mixed incontinence and mild-to-moderate symptoms effectively. Candidates typically include postpartum women, perimenopausal patients, and older women experiencing age-related pelvic floor decline. Emsella is not recommended for patients with certain metallic implants, active infections, or severe pelvic organ prolapse requiring surgical correction. A thorough consultation with a qualified provider helps determine whether HIFEM therapy suits individual patient anatomy and symptom severity.

What Did the New Comparative Study Between Emsella and Surgery Find?

Researchers conducted a prospective comparative study directly evaluating Emsella HIFEM therapy against surgical anterior colporrhaphy for women with stress urinary incontinence. The study published in MDPI Healthcare in 2026 included patients assessed at standardized intervals using validated incontinence questionnaires, pad tests, and clinical examination. Both treatment arms showed significant improvements from baseline, with the HIFEM group achieving comparable symptom reduction without surgical risks. Adverse events in the Emsella group were minimal and self-limiting, while the surgical cohort experienced typical post-operative complications including pain, bleeding, and infection risk.

How Was the Emsella vs Surgical Colporrhaphy Study Designed?

The prospective comparative study enrolled women diagnosed with stress urinary incontinence who were candidates for surgical intervention. Researchers randomized participants to receive either six Emsella sessions over three weeks or traditional anterior colporrhaphy with standardized surgical technique. Baseline characteristics including age, body mass index, incontinence severity, and pelvic floor muscle strength were comparable between groups. Outcome assessors remained blinded to treatment allocation, reducing bias in subjective symptom reporting. Patients completed follow-up evaluations at one, three, and six months post-treatment, providing longitudinal data on durability of results.

What Were the Efficacy Outcomes for Each Treatment?

Both treatment groups demonstrated statistically significant improvements in incontinence symptoms at all follow-up points. The Emsella group achieved mean reductions in incontinence episodes and pad weight similar to the surgical cohort. Patient satisfaction rates were comparable between groups, with the HIFEM-treated patients noting particular appreciation for the non-invasive nature of treatment. Quality-of-life scores improved markedly in both arms, reflecting the meaningful impact of symptom relief regardless of treatment modality. The findings suggest Emsella may serve as an effective alternative for appropriately selected patients seeking incontinence treatment.

Is the Emsella Kegel Throne as Effective as Surgical Repair?

Based on the 2026 comparative study data, Emsella HIFEM therapy produces clinically meaningful improvements in urinary incontinence symptoms comparable to anterior colporrhaphy for suitable candidates. The non-invasive treatment offers distinct advantages in safety profile and convenience while delivering equivalent symptomatic relief. Surgical repair remains appropriate for patients with significant anatomical defects or those who have failed conservative management. The choice between treatments should involve shared decision-making between patient and provider, weighing individual anatomy, symptom severity, and personal preferences.

What Are the Clinical Outcomes of HIFEM Therapy vs Surgery?

Clinical outcomes from the comparative study reveal that both modalities achieve similar reductions in incontinence severity scores and pad usage. Objective measurements including pelvic floor muscle strength and urethral mobility improved in both groups. Subgroup analysis suggested patients with mild-to-moderate SUI responded particularly well to HIFEM therapy, achieving outcomes nearly indistinguishable from surgical results. The study findings align with earlier research demonstrating Emsella efficacy, while adding the critical comparison to the gold-standard surgical alternative. Providers can now offer evidence-based guidance to patients weighing these options.

How Do Recovery Times Compare Between Emsella and Surgery?

Recovery time represents a stark contrast between these treatment approaches. Emsella requires no downtime; patients resume normal activities immediately following each 28-minute session. Minor warmth or tingling sensations during treatment resolve instantly post-session. Surgical anterior colporrhaphy typically involves four to six weeks of activity restriction, with patients advised to avoid heavy lifting, strenuous exercise, and sexual activity during healing. Post-operative pain, swelling, and catheter use characterize the immediate recovery period. For busy women in Orange County managing work, family, and personal commitments, the convenience of Emsella sessions offers a compelling advantage over surgical recovery demands.

What Are the Benefits of Choosing Emsella Over Surgery for Incontinence?

Emsella offers compelling advantages for women seeking incontinence treatment without surgical risks or recovery inconvenience. The treatment eliminates anesthesia requirements, incision sites, and infection risks associated with surgical repair. Patients appreciate the privacy of a fully clothed treatment experience that fits easily into lunch breaks or between daily obligations. The 2026 comparative study confirms that clinical efficacy need not be sacrificed for this convenience. For women in Tustin, Fountain Valley, and Laguna Beach who have delayed treatment due to fear of surgery, Emsella provides an accessible entry point to effective pelvic floor rehabilitation.

Why Do Patients Prefer Non-Invasive Treatment Options?

Patient preferences increasingly favor non-invasive treatments that minimize risk and disruption to daily life. Fear of surgery, anesthesia complications, and prolonged recovery deter many women from seeking needed care for urinary incontinence. Non-invasive alternatives address these barriers directly, enabling treatment-phobic patients to access effective therapy. The psychological burden of surgical decision-making, including concerns about surgical outcomes and body image changes, is eliminated with the Emsella approach. Industry data consistently shows growing demand for office-based treatments that deliver surgical-quality results without surgical infrastructure. This trend reflects broader healthcare preferences for minimally disruptive care pathways.

What Is the Treatment Protocol and Session Requirements?

The standard Emsella protocol involves six sessions, typically scheduled twice weekly over three weeks. Each session lasts approximately 28 minutes while the patient sits comfortably on the treatment chair. Patients remain fully clothed in loose, non-metallic garments during treatment. Some individuals experience mild tingling or muscle contractions during the session, described as intense but not painful. Maintenance sessions every six to twelve months help sustain results, though many patients experience prolonged improvement following the initial treatment series. A typical treatment course at Orange County Plastic Surgery includes comprehensive assessment, personalized protocol development, and ongoing follow-up to monitor outcomes.

Where Can You Get Emsella Treatment in Orange County?

Orange County Plastic Surgery offers Emsella HIFEM therapy at their Newport Beach facility, serving patients throughout the region including Tustin, Fountain Valley, and Laguna Beach. Dr. Juris Bunkis and Dr. Deborah Ekstrom provide comprehensive consultations to determine whether Emsella suits each patient’s unique anatomy and incontinence pattern. The practice combines state-of-the-art non-invasive technology with the expertise of board-certified plastic surgeons experienced in both surgical and non-surgical modalities. Scheduling flexibility accommodates busy lifestyles, with treatment sessions available throughout the week.

Is Emsella Available Near Tustin, Fountain Valley, or Laguna Beach?

Residents of Tustin, Fountain Valley, and Laguna Beach can access Emsella treatment at Orange County Plastic Surgery’s Newport Beach location, situated conveniently near major transportation corridors. The practice welcomes patients from throughout Orange County seeking advanced pelvic floor rehabilitation without surgery. New patients can schedule consultations to discuss symptoms, treatment expectations, and whether Emsella aligns with their health goals. The practice also offers comprehensive bioidentical hormone replacement therapy and other wellness services that may complement incontinence treatment.

Ready to Explore Your Incontinence Treatment Options?

The 2026 comparative study establishes Emsella as a credible non-invasive alternative to surgical anterior colporrhaphy for appropriately selected patients with urinary incontinence. Women in Orange County now have access to this evidence-based technology at Orange County Plastic Surgery, where Dr. Bunkis and Dr. Ekstrom provide expert evaluation and personalized treatment planning. Whether exploring Emsella as a first-line treatment or considering alternatives after conservative measures, a consultation with experienced providers helps determine the most appropriate pathway to improved bladder control and quality of life. Contact Orange County Plastic Surgery today to schedule your assessment and discover whether the Emsella Kegel Throne fits your needs.

Frequently Asked Questions

What is Emsella and how does it treat urinary incontinence?

Emsella is an FDA-cleared, non-invasive device using HIFEM technology to stimulate deep pelvic floor contractions. During a 28-minute session, it delivers approximately 11,000 supramaximal contractions – equivalent to 11,000 correctly-executed Kegel exercises. This strengthens pelvic floor musculature, restores urethral support, and improves bladder control without surgery.

How effective is Emsella compared to surgery for urinary incontinence?

A 2026 comparative study published in MDPI Healthcare found Emsella achieves comparable symptom reduction to surgical anterior colporrhaphy for stress urinary incontinence. Both groups showed statistically significant improvements in incontinence severity scores and pad usage, with similar patient satisfaction rates. The HIFEM group experienced minimal adverse events compared to typical post-operative complications in the surgical group.

What is the Emsella treatment protocol and how long does each session take?

The standard Emsella protocol involves six sessions scheduled twice weekly over three weeks. Each session lasts approximately 28 minutes while the patient sits comfortably on the treatment chair. Patients remain fully clothed in loose, non-metallic garments during treatment, with mild tingling or muscle contractions described as intense but not painful.

What is the recovery time for Emsella compared to surgery?

Emsella requires no downtime – patients resume normal activities immediately after each session. Minor warmth or tingling sensations resolve instantly post-session. Surgical anterior colporrhaphy requires four to six weeks of activity restriction, including avoiding heavy lifting, strenuous exercise, and sexual activity, with post-operative pain, swelling, and catheter use.

Who is a good candidate for Emsella HIFEM therapy?

Emsella is indicated for stress urinary incontinence (SUI) in women, including those with mixed incontinence and mild-to-moderate symptoms. Ideal candidates include postpartum women, perimenopausal patients, and older women experiencing age-related pelvic floor decline. It is not recommended for patients with metallic implants, active infections, or severe pelvic organ prolapse requiring surgical correction.

What are the main benefits of choosing Emsella over surgical repair?

Emsella eliminates anesthesia requirements, incision sites, and infection risks associated with surgical repair. The fully clothed treatment experience fits into lunch breaks or daily schedules with no recovery downtime. Clinical studies confirm efficacy comparable to surgery. Women who have delayed treatment due to fear of surgery find Emsella provides an accessible entry point to effective pelvic floor rehabilitation.

What did the 2026 comparative study between Emsella and surgery find?

A 2026 prospective comparative study published in MDPI Healthcare evaluated Emsella HIFEM therapy against surgical anterior colporrhaphy. Both treatment groups demonstrated statistically significant improvements at one, three, and six months follow-up, with comparable reductions in incontinence episodes and pad weight. Patient satisfaction rates were similar between groups, while the surgical cohort experienced typical post-operative complications.